Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults - Wikidata - awgldk - TriplyDB

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

http://www.wikidata.org/entity/Q35116285

about

Valaciclovir versus aciclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients Management of herpes zoster ophthalmicus in people with HIV infection Antiviral therapy for Ramsay Hunt syndrome (herpes zoster oticus with facial palsy) in adults Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy Varicella-zoster virus Vaccination against herpes zoster in developed countries: state of the evidence Recommendations for the Management of Herpes Zoster Varicella zoster virus. Recent advances in management Phase specific analysis of herpes zoster associated pain data: a new statistical approach.Guanosine analogues as anti-herpesvirus agents.One-year low-dose valacyclovir as prophylaxis for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation. A prospective study of the Japan Hematology and Oncology Clinical Study Group.Postherpetic neuralgia.Antifungal and antiviral agents: a review.Antiinfectives update: focus on treatment and prevention of viral and associated infections.Recent advances in antiviral therapy.Virus infections of the eye.Burden of post-herpetic neuralgia in a sample of UK residents aged 50 years or older: findings from the Zoster Quality of Life (ZQOL) study Management and prevention of herpes zoster: A Canadian perspective.Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group Emerging drugs for varicella-zoster virus infections.Postherpetic neuralgia in the cancer patient.Test systems to identify reproductive toxicants.Higher dose versus lower dose of antiviral therapy in the treatment of herpes zoster infection in the elderly: a matched retrospective population-based cohort study.Management of herpes simplex and varicella-zoster virus infections Post herpetic neuralgia and the dermatologist.Herpes zoster in older adults.The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study Presentation and management of herpes zoster (shingles) in the geriatric population.Clinical practice: Herpes zoster Acyclic/carbocyclic guanosine analogues as anti-herpesvirus agents.Burden of herpes zoster in the UK: findings from the zoster quality of life (ZQOL) study.Valacyclovir in the treatment of herpes simplex, herpes zoster, and other viral infections.Herpes zoster infection and postherpetic neuralgia.Herpes simplex virus resistance to acyclovir and penciclovir after two decades of antiviral therapy Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency Race and stress in the incidence of herpes zoster in older adults.Understanding pain in herpes zoster: an essential for optimizing treatment.Consequences and management of pain in herpes zoster.Tomorrow's challenges for herpesvirus management: potential applications of valacyclovir.

P2860

Q24186823-360D60F1-5B08-424D-941A-986B0405D8A2 Q24234863-6AE535BB-DD63-4E64-983B-7E873D07F4AD Q24241456-3360ACC6-8F21-4E55-9BCD-F46A3D06233C Q24649099-DCD4E766-8DCE-45A7-94B2-1AABF27E74F9 Q24672068-5ED9948A-A4C8-4127-9D23-7A0556CDA26A Q24683811-DCB7D7D6-5F1E-4BB0-BF60-DB789F415791 Q26862748-C6942131-A3F7-4894-BF39-D7FAC2F83937 Q28315869-A382EF55-D403-4DB5-A459-21DD8D43A279 Q28344239-6914B369-EEBD-4B7B-A097-B89E33FF0000 Q31955443-94FF97B4-02F3-4C52-9DC5-54268AADC975 Q31996846-9253DC6D-2BA3-4077-AF76-6FE66AC146A6 Q33390725-BF41AAA3-54A8-459A-9F18-3BBB8F60069D Q33448304-23F07AED-E1CC-4AFC-8364-9CEC2428D398 Q33539956-DAF76FD7-96FE-4A37-8569-ECB969B1FB8E Q33659379-6648D9F0-A5DE-492A-B740-E521893B5CC3 Q33681664-66CC75EC-2F3D-418A-948E-B0F0E06354FC Q33682990-6C625944-DB95-4701-BA97-7AC300F307B4 Q33776676-2B97EABA-6AEA-46A4-891A-5DB95544113A Q33779986-DC10DEDD-A4C3-4966-B9A0-4AC6E5DFC862 Q33936572-E7B97FCB-8DBE-4387-9000-127BAB528700 Q34027426-9F96FF55-EB32-4ABE-A328-5BC8B931A9AE Q34040576-75568737-513C-41A8-8D35-B597E51E5C58 Q34054691-A2621B3D-1E7F-44F4-9DA6-C5B7DEC9C464 Q34152542-D983391A-90CE-46DE-8838-1CD6B952DC47 Q34185463-111F85F0-330B-4BA7-8733-8EE6F190B067 Q34201573-9AEE6DC8-72AE-4E99-9B77-11F959BD3D27 Q34228634-25E7F97D-0727-4FD3-8E36-AB5A53A4E2DB Q34273914-AE6CC7D8-9AB3-4B7C-969F-99C1D7EE2CA9 Q34352218-56E2B822-34EF-418C-B436-BB3EBC3F5337 Q34358014-9208F4BA-EA53-42F4-B289-891F902E50FD Q34373532-3BEB32D5-57FA-4DB7-96E4-44400FE15789 Q34468957-4E182965-C752-4A4D-8AAD-A191CA91575B Q34542157-1ED6A299-E4A7-4641-93CA-B3B531D79BCB Q34566610-5DAFC3BD-A485-4192-B9D9-E04362015911 Q34579981-A1343F1D-84B5-4864-99F0-6F78661E4580 Q34594761-8CB0FB5A-30A3-4466-877F-A95E5FCCE1F8 Q34750739-301EC089-623E-4E6F-A4F6-E315F645CCF7 Q34918366-A5C38725-17E5-480F-98B4-4C53A045A479 Q34918383-53842B45-B609-44EC-990A-023B2D815316 Q34918468-6685289B-D1D9-4572-829E-2BC94EF8EEC8

P2860

Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults

http://www.wikidata.org/entity/Q35116285

description

1995 nî lūn-bûn

@nan

1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Valaciclovir compared with acy ...... ster in immunocompetent adults

@ast

Valaciclovir compared with acy ...... ster in immunocompetent adults

@en

type

label

Valaciclovir compared with acy ...... ster in immunocompetent adults

@ast

Valaciclovir compared with acy ...... ster in immunocompetent adults

@en

prefLabel

Valaciclovir compared with acy ...... ster in immunocompetent adults

@ast

Valaciclovir compared with acy ...... ster in immunocompetent adults

@en

P1433

Q35116285-F8E2124A-A82B-4F90-863A-DC245AA5928D

P1476

Q35116285-9D412018-014E-48C2-935A-02A878520240

P2093

Q35116285-17167DF4-8868-49C7-BAD0-E274011AFB39

Q35116285-64078D02-C3B7-4EFE-90D3-00A0ED183A36

Q35116285-689CDA4A-0ECF-42B1-915E-161609C24229

Q35116285-9F9CA033-CFAE-47EC-8756-95CB8BCFDC71

Q35116285-E9EB511E-1463-4AEE-9252-871C3E954C70

P2860

Q35116285-06F199AD-7820-452F-8047-801F830F576F

Q35116285-072F3E8A-A46F-42F8-9CB2-E7166530B85A

Q35116285-0B8571DE-FC0D-485C-9AD0-7C11A7FFDCDA

Q35116285-1CB39B95-2BCB-4474-9BB6-74065F465D89

Q35116285-29AC36BD-A727-4C02-A5C3-A0F2513BCCC5

Q35116285-344585B6-91A8-433D-8B87-5791F9D5DCEE

Q35116285-381B18AC-1CD4-4E9F-ACF9-507F1A75E36A

Q35116285-3E556553-776A-44E3-8566-0E2EBA59CE56

Q35116285-961D7ED2-32D2-4D60-BE2B-02EB7E66CDCD

Q35116285-9784D459-D979-4D24-8DE3-F559493829A8

P304

Q35116285-32434183-FE04-4BB5-9FD1-E46D4C76DDEB

P31

Q35116285-83332E79-768D-4B51-AAE6-04176B938830

P356

Q35116285-3D508F43-9D77-4630-9597-97E004B6D1BB

P407

Q35116285-EFE35554-BA37-4C09-8473-9C156DB84264

P433

Q35116285-AEAF13CE-446C-46D8-A6AC-898382CD0F0F

P478

Q35116285-B9188FC9-FD2A-4FA9-8A28-8E089D226054

P577

Q35116285-74DAF269-BA34-4A7C-86A1-9C767D32B4AA

P698

Q35116285-4E8972B7-3925-4EB9-A923-CED7E6CF3F83

P932

Q35116285-06C34825-A39C-47CE-BAE2-DEE727A9C0B4

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Valaciclovir compared with acy ...... ster in immunocompetent adults

@en

P2093

Andersen PL

http://www.w3.org/2001/XMLSchema#string

Beutner KR

http://www.w3.org/2001/XMLSchema#string

Forszpaniak C

http://www.w3.org/2001/XMLSchema#string

Friedman DJ

http://www.w3.org/2001/XMLSchema#string

Wood MJ

http://www.w3.org/2001/XMLSchema#string

P2860

THE NATURE OF HERPES ZOSTER: A LONG-TERM STUDY AND A NEW HYPOTHESIS

The natural history of herpes zoster.

Oral acyclovir in the treatment of acute herpes zoster ophthalmicus.

A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster.

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers.

Acyclovir: a decade later.

Therapeutic approaches to varicella-zoster virus infections.

Zoster-associated chronic pain: an overview of clinical trials with acyclovir.

Efficacy of oral acyclovir treatment of acute herpes zoster.

Narcotic analgesia: fentanyl reduces the intensity but not the unpleasantness of painful tooth pulp sensations.

P304

1546-1553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.39.7.1546

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

1995-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7492102

http://www.w3.org/2001/XMLSchema#string

P932

162779

http://www.w3.org/2001/XMLSchema#string